A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Stryker Corp stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 89,611 shares of SYK stock, worth $32.7 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
89,611
Previous 103,787 13.66%
Holding current value
$32.7 Million
Previous $35.3 Million 8.34%
% of portfolio
0.32%
Previous 0.37%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$315.94 - $371.96 $4.48 Million - $5.27 Million
-14,176 Reduced 13.66%
89,611 $32.4 Million
Q2 2024

Aug 13, 2024

BUY
$324.3 - $354.67 $1.84 Million - $2.02 Million
5,683 Added 5.79%
103,787 $35.3 Million
Q1 2024

May 15, 2024

SELL
$293.94 - $358.71 $1.55 Million - $1.89 Million
-5,257 Reduced 5.09%
98,104 $35.1 Million
Q4 2023

Feb 13, 2024

SELL
$253.85 - $299.46 $3.44 Million - $4.05 Million
-13,534 Reduced 11.58%
103,361 $31 Million
Q3 2023

Nov 13, 2023

SELL
$266.54 - $302.43 $170,585 - $193,555
-640 Reduced 0.54%
116,895 $31.9 Million
Q2 2023

Aug 11, 2023

BUY
$271.49 - $305.09 $5.85 Million - $6.58 Million
21,552 Added 22.45%
117,535 $35.9 Million
Q1 2023

May 10, 2023

BUY
$246.13 - $285.47 $4.74 Million - $5.5 Million
19,278 Added 25.13%
95,983 $27.4 Million
Q4 2022

Feb 13, 2023

BUY
$205.51 - $253.93 $607,076 - $750,109
2,954 Added 4.01%
76,705 $18.8 Million
Q3 2022

Nov 14, 2022

SELL
$189.27 - $231.83 $593,172 - $726,555
-3,134 Reduced 4.08%
73,751 $14.9 Million
Q2 2022

Aug 12, 2022

SELL
$194.09 - $276.37 $176,815 - $251,773
-911 Reduced 1.17%
76,885 $15.3 Million
Q1 2022

May 10, 2022

BUY
$245.33 - $277.77 $643,991 - $729,146
2,625 Added 3.49%
77,796 $20.8 Million
Q4 2021

Feb 11, 2022

BUY
$236.63 - $276.44 $17.8 Million - $20.8 Million
75,171 New
75,171 $20.3 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $138B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.